The two-edged sword: Vasculitis associated with HIV and hepatitis C coinfection

International Journal of STD and AIDS

Volumn 25, Issue 2, 2014, Pages 77-88

  Ojaimi, Samar ^a,b   Lin, Ming Wei ^b,c   Singh, Kasha P ^d,e   Woolley, Ian ^a,e  

^a Southern Health ^*  (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e MONASH UNIVERSITY   (Australia)

Author keywords

AIDS; cryoglobulinaemia; hepatitis C; HIV; HIV HCV coinfection; vasculitis

Indexed keywords

ANTIRETROVIRUS AGENT; AZATHIOPRINE; BOCEPREVIR; CORTICOSTEROID; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD20; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA; RIBAVIRIN; RITUXIMAB; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RNA;

ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL THERAPY; BRAIN VASCULITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; EPIDEMIC; EPIDEMIOLOGICAL DATA; GIANT CELL ARTERITIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGAMMAGLOBULINEMIA; IMMUNE COMPLEX DISEASE; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTOCLASTIC VASCULITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCREENING TEST; SYSTEMIC DISEASE; SYSTEMIC VASCULITIS; VASCULITIS; VIRAL CLEARANCE; VIRUS LOAD; VIRUS STRAIN; WEGENER GRANULOMATOSIS;

AIDS; CRYOGLOBULINAEMIA; HEPATITIS C; HIV; HIV/HCV COINFECTION; VASCULITIS;

ANTIVIRAL AGENTS; COINFECTION; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; RNA, VIRAL; VASCULITIS;

EID: 84893482139     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413495671     Document Type: Review

References (72)

1. Guillevin L,Dörner T.Vasculitis: mechanisms involved and clinical manifestations.Arthritis Res Ther. 2007;9:S9-S9.
2. Guillevin L.Vasculitides in the context of HIV infection.AIDS. 2008;22:S27-S33.
3. Guillevin L,Pagnoux C.Therapeutic strategies for systemic necrotizing vasculitides.Allergol Int. 2007;56:105-111.
4. Jennette JC,Falk RJ,Andrassy K, et al.Nomenclature of systemic vasculitides.Arthritis Rheum. 1994;37:187-192.
5. Belizna CC,Hamidou MA,Levesque H, et al.Infection and vasculitis.Rheumatology. 2008;48:475-482.
6. Trepo C,Guillevin L.Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis.J Autoimmun. 2001;16:269-274.
7. Sene D,Limal N,Cacoub P.Hepatitis C virus-associated extrahepatic manifestations: a review.Metab Brain Dis. 2004;19:357-381.
8. Cebrián M,Miró O,Font C, et al.HIV-related vasculitis.AIDS Patient Care STDs. 1997;11:245-258.
9. Guillevin L.Virus-induced systemic vasculitides: new therapeutic approaches.Clin Dev Immunol. 2004;11:227-231.
10. Chetty R.Vasculitides associated with HIV infection.J Clin Pathol. 2001;54:275-278.
11. Gherardi R,Belec L,Mhiri C, et al.The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation.Arthritis Rheum. 1993;36:1164-1174.
12. Guillevin L,Lhote F,Gherardi R.The spectrum and treatment of virus-associated vasculitides.Curr Opin Rheumatol. 1997;9:31-36.
13. Kosmas N,Kontos A,Panayiotakopoulos G, et al.Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients.J Med Virol. 2006;78:1257-1261.
14. Zhang X,Li H,Li T, et al.Distinctive rheumatic manifestations in 98 patients with human immunodeficiency virus infection in China.J Rheumatol. 2007;34:1760-1764.
15. Tinkle BT,Ngo L,Luciw PA, et al.Human immunodeficiency virus-associated vasculopathy in transgenic mice.J Virol. 1997;71:4809-4814.
16. Johnson RM,Barbarini G,Barbaro G.Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients.AIDS. 2003;17:S77-82.
17. Cuellar ML,Espinoza LR.Rheumatic manifestations of HIV-AIDS.Best Pract Res Clin Rheumatol. 2000;14:579-593.
18. Brannagan TH.Retroviral-associated vasculitis of the nervous system.Neurol Clin. 1997;15:927-944.
19. Zandman-Goddard G,Shoenfeld Y.HIV and autoimmunity.Autoimmun Rev. 2002;1:329-337.
20. Gherardi R,Lebargy F,Gaulard P, et al.Necrotizing vasculitis and HIV replication in peripheral nerves.N Engl J Med. 1989;321:685-686.
21. Reveille JD.The changing spectrum of rheumatic disease in human immunodeficiency virus infection.Semin Arthritis Rheum. 2000;30:147-166.
22. Martínez-Rojano H,Juárez Hernández E,Ladrón De Guevara G, et al.Rheumatologic manifestations of pediatric HIV infection.AIDS Patient Care STDs. 2001;15:519-526.
23. Jansen TLTA,van Houte D,de Vries T, et al.ANCA seropositivity in HIV: a serological pitfall.Neth J Med. 2005;63:270-274.
24. Cornely OA,Hauschild S,Weise C, et al.Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection.Infection. 1999;27:92-96.
25. Savige JA,Chang L,Crowe SM.Anti-neutrophil cytoplasm antibodies in HIV infection.Adv Exp Med Biol. 1993;336:349-352.
26. Klaassen RJ,Goldschmeding R,Dolman KM, et al.Anti-neutrophil cytoplasmic autoantibodies in patients with symptomatic HIV infection.Clin Exp Immunol. 1992;87:24-30.
27. Melica G,Brugieres P,Lascaux A-S, et al.Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era.J Med Virol. 2009;81:578-581.
28. Ferrari S,Lanzafame M,Faggian F, et al.Painful neuropathy vasculitis in 2 patients with long-standing human immunodeficiency virus-1 infection.Scand J Infect Dis. 2004;36:392-393.
29. Font C,Miró O,Pedrol E, et al.Polyarteritis nodosa in human immunodeficiency virus infection: report of four cases and review of the literature.Br J Rheumatol. 1996;35:796-799.
30. Sambatakou H,Tsiachris D,Stamouli S, et al.Systemic vasculitis with gastrointestinal involvement in an HIV-infected adult.Am J Med Sci. 2008;335:237-238.
31. Stankovic K,Miailhes P,Bessis D, et al.Kawasaki-like syndromes in HIV-infected adults.J Infect. 2007;55:488-494.
32. Velez AP,Menezes L,Crespo A.Kawasaki-like syndrome possibly associated with immune reconstitution inflammatory syndrome in an HIV-positive patient.AIDS Read. 2006;16:464-466.
33. Reveille JD,Williams FM.Rheumatologic complications of HIV infection.Best PractRes Clin Rheumatol. 2006;20:1159-1179.
34. Nair R,Robbs JV,Naidoo NG, et al.Clinical profile of HIV-related aneurysms.Eur J Vasc Endovasc Surg. 2000;20:235-240.
35. Pagnoux C,Cohen P,Guillevin L.Vasculitides secondary to infections.Clin Exp Rheumatol. 2006;24:S71-S71.
36. Maganti RM,Reveille JD,Williams FM.Therapy insight: the changing spectrum of rheumatic disease in HIV infection.Nat Clin Pract Rheumatol. 2008;4:428-438.
37. Vassilopoulos D,Calabrese LH.Extrahepatic immunological complications of hepatitis C virus infection.AIDS. 2005;19:S123-7.
38. Buskila D. Hepatitis C-associated rheumatic disorders. Rheumat Dis Clinics NA. 2009;35:111-123.
39. Cacoub P,Saadoun D,Limal N, et al.Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications.AIDS. 2005;19:S128-134.
40. Sansonno D,Carbone A,De Re V, et al.Hepatitis C virus infection, cryoglobulinaemia, and beyond.Rheumatology (Oxford). 2007;46:572-578.
41. Saadoun D,Landau DA,Calabrese LH, et al.Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation.Rheumatology. 2007;46:1234-1242.
42. Vassilopoulos D,Calabrese LH.Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies.Arthritis Rheum. 2002;46:585-597.
43. Agmon-Levin N,Ram M,Barzilai O, et al.Prevalence of hepatitis C serum antibody in autoimmune diseases.J Autoimmun. 2009;32:261-266.
44. Cacoub P,Saadoun D.Hepatitis C virus infection induced vasculitis.Clinic Rev Allerg Immunol. 2008;35:30-39.
45. Sansonno D,Dammacco F.Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations.Lancet Infect Dis. 2005;5:227-236.
46. Delluc A,Saadoun D,Ghillani-Dalbin P, et al.Cryofibrinogen in patients with hepatitis c virus infection.Am J Med. 2008;121:624-631.
47. De Vita S,Quartuccio L,Fabris M,Hepatitis C.virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?.Autoimmun Rev. 2008;8:95-99.
48. Nityanand S,Holm G,Lefvert AK.Immune complex mediated vasculitis in hepatitis B and C infections and the effect of antiviral therapy.Clin Immunol Immunopathol. 1997;82:250-257.
49. Saadoun D,Bieche I,Maisonobe T, et al.Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.Arthritis Rheum. 2005;52:2917-2925.
50. Saadoun D,Boyer O,Trébeden-Nègre H, et al.Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis.J Hepatol. 2004;41:1031-1037.
51. Pietrogrande M,De Vita S,Zignego AL, et al.Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.Autoimmun Rev. 2011;10:444-454.
52. Saadoun D,Resche-Rigon M,Thibault V, et al.Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study.Arthritis Rheum. 2006;54:3696-3706.
53. Saadoun D,Rosenzwajg M,Landau D, et al.Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.Blood. 2008;111:5334-5341.
54. Harcourt G.Diminished frequency of hepatitis C virus specific interferon secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients.Gut. 2006;55:1484-1487.
55. Cooper CL.An overview of HIV and chronic viral hepatitis co-infection.Dig Dis Sci. 2008;53:899-904.
56. McGovern BH.Hepatitis C in the HIV-infected patient.J Acquir Immune Defic Syndr. 2007;45:S47-56; discussion S66-67.
57. Butt AA,Tsevat J,Ahmad J, et al.Biochemical and virologic parameters in patients co-infected with hepatitis C and HIV versus patients with hepatitis C mono-infection.Am J Med Sci. 2007;333:271-275.
58. Danta M,Semmo N,Fabris P, et al.Impact of HIV on host-virus interactions during early hepatitis C virus infection.J Infect Dis. 2008;197:1558-1566.
59. Yoo TW,Donfield S,Lail A, et al.Hemophilia growth and development study. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease.J Infect Dis. 2005;191:4-10.
60. Woitas RP,Stoschus B,Terjung B, et al.Hepatitis C-associated autoimmunity in patients coinfected with HIV.Liver Int. 2005;25:1114-1121.
61. Bonnet F,Pineau J-J,Taupin J-L, et al.Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.J Rheumatol. 2003;30:2005-2010.
62. Aaron L,Lebray P,Alyanakian M-A, et al.Prevalence of mixed cryoglobulins in relation to CD4 cell count among patients coinfected with HIV and hepatitis C virus.Clin Infect Dis. 2005;40:306-308.
63. Cacoub P,Renou C,Rosenthal E, et al.Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients.Medicine. 2000;79 (1): 47-56.
64. Scotto G,Cibelli DC,Saracino A, et al.Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection.J Infect. 2006;52:294-299.
65. Saadoun D,Aaron L,Resche-Rigon M, et al.Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.AIDS. 2006;20:871-877.
66. Ramos-Casals M,Forns X,Brito-Zerón P, et al.Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection.J Viral Hepat. 2007;14 (10): 736-742.
67. Lapinski TW,Parfieniuk A,Rogalska-Plonska M, et al.Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.Liver Int. 2009;29:1158-1161.
68. Fabris P,Tositti G,Giordani MT, et al.Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus.J. Med. Virol. 2003;69:339-343.
69. Dezzutti CS,Astemborski J,Thomas DL, et al.Prevalence of cryoglobulinemia in hepatitis C virus (HCV) positive patients with and without human immunodeficiency virus (HIV) coinfection.J Clin Virol. 2004;31:210-214.
70. Antinori S,Galimberti L,Rusconi S, et al.Disappearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection.Clin Exp Rheumatol. 1995;13:S157-S157.
71. Monsuez JJ,Vittecoq D,Musset L, et al.Arthralgias and cryoglobulinemia during protease inhibitor therapy in a patient infected with human immunodeficiency virus and hepatitis C virus.Arthritis Rheum. 1998;41:740-743.
72. Dimitrakopoulos AN,Kordossis T,Hatzakis A, et al.Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1.Ann Intern Med. 1999;130:226-230.